AIFM2 and cancer: These include inhibition of PUFA‐PLs synthesis and peroxidation, restriction of labile iron availability, and upregulation of cellular defense systems such as SLC7A11, GPX4, and FSP1, all of which enable cancer cells to bypass ferroptosis and continue proliferating.5